BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 24, 2012
View Archived Issues
Ranbaxy discloses novel matrix metalloproteinase inhibitors
Read More
Abbott reflects on accomplishments of first quarter 2012
Read More
Pfizer prepares new voltage-gated potassium channel activators
Read More
New HCV NS5A inhibitors patented by Merck & Co.
Read More
New candidate AstraZeneca antibacterial is active in vivo
Read More
First phase II data presented on BMS-791325 in hepatitis C
Read More
New HCV NS5B conformational modulator set for clinical testing
Read More
Discovery of clinical-stage c-Met inhibitor described
Read More
Optimized human protein inhibits thrombosis and neointima formation in vein grafts
Read More
Biota and Nabi to form combined company
Read More
Novel beta-secretase inhibitors presented by Janssen
Read More
Scripps Research receives grant to develop new eye disease treatments
Read More
Phase II trial of first-in-class defensin mimetic meets objectives
Read More
EnVivo reports new phosphodiesterase 9A inhibitors
Read More
Auris Medical completes enrollment in AM-111 trial
Read More
Ezose Sciences and Hirosaki University enter glycomics partnership
Read More
Resverlogix reveals lead candidate's mechanism of action
Read More
Asubio begins phase II study in acute spinal cord injury
Read More
Seikagaku and Biotie terminate license agreement
Read More
Phase III Latuda trials meet endpoints
Read More
Phase I RK-023 study for eyelash hypotrichosis complete
Read More
DMC recommends continuation of pivotal ThermoDox study
Read More
Fourth phase III study of QVA-149 in COPD meets primary endpoint
Read More
RaQualia selects potential IBS treatment for further development
Read More
Novo Nordisk and Oxford University launch novel collaboration
Read More